Durability of viral response to interferon alone or in combination with oral ribavirin in patients with chronic hepatitis C.

被引：0
|
作者：
Davis, G
McHutchison, J
Poynard, T
Esteban-Mur, R
Albrecht, J
Cort, S
Ling, MH
Garaud, JJ
机构：
[1] Univ Florida, Coll Med, Gainesville, FL USA
[2] Scripps Clin & Res Fdn, La Jolla, CA 92037 USA
[3] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[4] Hosp Gen Valle Hebron, Barcelona, Spain
[5] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
570
引用
收藏
页码：303A / 303A
页数：1
相关论文
共 50 条
  • [11] Hepatic iron concentration does not predict response to interferon/ribavirin combination therapy in patients with chronic hepatitis C.
    Hofer, H
    Steindl-Munda, P
    Kazemi-Shirazi, L
    Datz, C
    Mueller, C
    Penner, E
    Ferenci, P
    HEPATOLOGY, 1999, 30 (04) : 198A - 198A
  • [12] Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone
    Min, AD
    Jones, JL
    Esposito, S
    Lebovics, E
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Geders, JM
    Tobias, H
    Bodian, C
    Bodenheimer, HC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (04): : 1143 - 1149
  • [13] Effect of initial interferon dosing and dose on response to combination therapy with ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Salzburg, LKH
    Steindl-Munda, P
    GASTROENTEROLOGY, 1999, 116 (04) : A1209 - A1209
  • [14] High dose interferon alpha-2a treatment alone or in combination with ribavirin and amantadine in patients with hemophilia and chronic hepatitis C.
    Zimmermann, R
    Huth-Kuehne, A
    Lages, P
    Kallinowski, B
    Goeser, T
    Heinrichs, C
    Klamroth, R
    BLOOD, 2000, 96 (11) : 264A - 264A
  • [15] Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
    Asahina, Y
    Izumi, N
    Enomoto, N
    Uchihara, M
    Kurosaki, M
    Onuki, Y
    Nishimura, Y
    Ueda, K
    Tsuchiya, K
    Nakanishi, H
    Kitamura, T
    Miyake, S
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 623 - 629
  • [16] Immunological action of ribavirin monotherapy preceding to combination therapy with interferon for patients with chronic hepatitis C.
    Ogawa, K
    Hige, S
    Chuma, M
    Nagasaka, A
    Asaka, M
    HEPATOLOGY, 2004, 40 (04) : 393A - 393A
  • [17] Retreatment of chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Vandelli, C
    Renzo, F
    Vecchi, C
    Lovato, E
    Tisminetzky, S
    Ventura, E
    JOURNAL OF HEPATOLOGY, 2000, 32 : 191 - 191
  • [18] Genotypes 1 and 3 as predictors of response to alpha interferon ribavirin combination in Brazilians with chronic hepatitis C.
    Bassit, L
    RibeirodosSantos, G
    SaezAlquezar, A
    Chamone, DF
    Barros, MFA
    Marujo, WC
    Curry, RA
    SetteJunior, H
    HEPATOLOGY, 1997, 26 (04) : 353 - 353
  • [19] Virologic response in patients with chronic hepatitis C after treatment with interferon 2b alone or in combination with ribavirin.
    Futuh, ARA
    Solayman, AEM
    El Hendawy, SM
    El Hadad, SM
    Omar, MM
    Kamel, MM
    HEPATOLOGY, 2002, 36 (04) : 589A - 589A
  • [20] Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C
    Aguilar Reina, J.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (10) : 665 - 667
12345